21 November 2023: Original Paper
Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors
Mikołaj Kuncewicz 1BCDEF , Igor Piotr Jaszczyszyn 1BCDE , Kacper Karaban 1BCDE , Paweł Rykowski 1DEF* , Maciej Krasnodębski 1ADE , Marcin Morawski 1EF , Emilia Kruk 1B , Łukasz Koperski 2BC , Krzysztof Zieniewicz 1EF , Marek Krawczyk 1AEF , Michał Grąt 1AEFDOI: 10.12659/AOT.941212
Ann Transplant 2023; 28:e941212
Table 1 Eligibility criteria for LT in patients with NELM.
| Portal drainage of primary | NET G1/G2 | Ki67 | No sign of extrahepatic disease | Liver involvement | Stable disease for 6–12 months | Recipient age |
|---|---|---|---|---|---|---|
| − | + | ≤20% | + | − | + | − |
| “+” – required in our center, “−“ – not required in our center | ||||||